
Caire Health is revolutionizing emergency care with its AI-driven imaging solution, Caire Head CT, which enhances the speed and accuracy of diagnosing intracranial hemorrhages (ICH). The platform integrates seamlessly with existing hospital systems, allowing for rapid identification and treatment of emergent pathologies, thereby improving patient outcomes and reducing the burden on healthcare professionals. With proven sensitivity and specificity rates exceeding 97%, Caire Health positions itself as a leader in diagnostic AI, addressing critical challenges in emergency medicine and streamlining operations for hospitals and clinics.

Caire Health is revolutionizing emergency care with its AI-driven imaging solution, Caire Head CT, which enhances the speed and accuracy of diagnosing intracranial hemorrhages (ICH). The platform integrates seamlessly with existing hospital systems, allowing for rapid identification and treatment of emergent pathologies, thereby improving patient outcomes and reducing the burden on healthcare professionals. With proven sensitivity and specificity rates exceeding 97%, Caire Health positions itself as a leader in diagnostic AI, addressing critical challenges in emergency medicine and streamlining operations for hospitals and clinics.
Core product: AI software (Caire Head CT) for rapid detection of intracranial hemorrhage
Primary use case: Emergency care diagnostics to speed and improve ICH detection
Reported performance: Sensitivity and specificity rates reported as exceeding 97%
Stage (per profiles): Early-stage (Pre-Seed / Seed)
Headquarters: Ball Ground, Georgia, United States
Emergency medicine diagnostics — rapid detection of intracranial hemorrhage from head CT
Healthtech / Medical AI
Crunchbase lists one funding round (Seed) dated Sep 1, 2023; other profiles reference a Pre-Seed round with Y Combinator noted
130000.00
Dataset includes a last funding date of 2021-08-31 with total_funding_amount 130000.00 USD